These GLP-1 drugs have proven effective at helping people lose weight—and are showing promise for a host of other indications ...

President Donald Trump says he’ll sign an executive order on Monday intended to lower the cost of drugs in the U.S.

The proposal would likely only impact certain drugs covered by Medicare and given in an office — think infusions that treat ...

CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed ...

People taking Eli Lilly’s obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk’s Wegovy in ...

Medicare recipients suffering from obesity must pay out of pocket for weight loss drugs like Wecovy and Zepbound.